# LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

> **NCT00906048** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 10 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Levofloxacin (HR355) and Rifampicin Therapy

## Key facts

- **NCT ID:** NCT00906048
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2011-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906048, "LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00906048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*